Everyone seems to agree on one thing: mosquitoes are a huge nuisance. While they might just ruin a picnic for some, they are a serious threat to millions worldwide due to the diseases they spread. Mosquito-borne illnesses, such as malaria, West Nile virus, yellow fever, and dengue fever, cause immense suffering and claim over a million lives each year.
Malaria is one of the deadliest mosquito-borne diseases, killing around half a million people annually. Although some diseases like malaria are declining, others, such as dengue fever, are on the rise. Dengue cases have increased 30-fold in the last 30 years. Efforts to combat these diseases include vaccines, insecticides, education, and prevention programs. However, these efforts require significant funding and coordination across regions, and progress is often slow. Additionally, mosquitoes and parasites are developing resistance to current drugs and insecticides, making the fight even harder.
In response to these challenges, scientists are exploring a bold and controversial solution: genetically modified (GM) mosquitoes. The idea is to release GM mosquitoes to potentially eradicate certain mosquito species, thus eliminating the vectors for many deadly diseases. This summer, Florida and Texas might see the release of GM Aedes aegypti mosquitoes, marking the first such release in the U.S.
The GM mosquitoes, developed by Oxitec, are male Aedes aegypti mosquitoes branded as “Friendly” mosquitoes. These mosquitoes carry a self-limiting gene that prevents their offspring from reaching adulthood. The gene is introduced into mosquito eggs, and the larvae are reared with tetracycline, an antibiotic that allows them to survive until adulthood. When these GM mosquitoes breed with wild mosquitoes, their offspring inherit the lethal gene and die without tetracycline.
Recent advancements have enabled scientists to target only female offspring, which are the ones that bite and spread diseases. This approach could significantly reduce mosquito populations over several generations, potentially protecting communities from diseases like dengue, yellow fever, and Zika without using insecticides.
Previous field trials in countries like Brazil, Panama, and Malaysia have shown promising results, with mosquito populations reduced by up to 98% in some cases. However, the safety of GM mosquitoes is a major concern. Critics worry about potential gene transfer to humans or other animals, although studies suggest this is unlikely. Environmental impacts, such as disrupting the food chain, are also a concern, but the focus is currently on the invasive Aedes aegypti species, which is not a keystone species in Florida or Texas.
The release of GM mosquitoes has sparked debate, with significant public opposition in some areas. While Oxitec has conducted rigorous testing, concerns about transparency and bias remain. Despite these challenges, the potential benefits of this technology in combating mosquito-borne diseases are significant.
As our understanding of genetics advances, genetic engineering will likely play a crucial role in shaping our future. While uncertainties and controversies exist, the potential to save millions of lives makes exploring these technologies worthwhile.
Engage in a structured debate on the ethical implications and potential environmental impacts of releasing genetically modified mosquitoes. Split into groups, with each group representing different stakeholders such as scientists, environmentalists, public health officials, and local communities. Prepare arguments and counterarguments to present in a panel discussion.
Conduct research on the current status of mosquito-borne diseases globally. Focus on the effectiveness of traditional control methods versus innovative solutions like genetically modified mosquitoes. Present your findings in a multimedia presentation, highlighting key statistics and potential future trends.
Analyze a case study of a previous field trial involving genetically modified mosquitoes, such as those conducted in Brazil or Malaysia. Evaluate the outcomes, challenges faced, and lessons learned. Discuss how these insights could apply to the proposed releases in Florida and Texas.
Participate in a workshop that explores the science behind genetic modification. Learn about the techniques used to create genetically modified organisms, specifically focusing on the self-limiting gene in mosquitoes. Discuss the potential applications and limitations of genetic engineering in public health.
Design and conduct a survey to gauge public opinion on the release of genetically modified mosquitoes. Analyze the data to understand the level of support or opposition and the reasons behind people’s views. Present your findings in a report, offering recommendations for addressing public concerns.
Here’s a sanitized version of the provided YouTube transcript:
—
This episode of Real Science is brought to you by Curiosity Stream. Sign up today at curiositystream.com/realscience and get free access to watch Nebula.
[Music]
It’s the one thing everyone can agree on: mosquitoes are the worst. For some, they are simply the ruiners of picnics and camping trips, but for a significant portion of the world, they are much more than a nuisance. Mosquitoes cause more human suffering than any other organism due to the horrific diseases they carry. Over a million people worldwide die from mosquito-borne diseases every year.
In a previous video, I discussed malaria, perhaps the most devastating of all mosquito-borne illnesses, killing about half a million people each year. While less common, other diseases like West Nile virus, yellow fever, and dengue fever are insidious in their own ways, debilitating and deadly to many in the tropics and subtropics. Some diseases like malaria are declining, but others like dengue are very much on the rise. In the past 30 years, the worldwide incidence of dengue has risen 30-fold. Billions are spent trying to combat these diseases through vaccines, insecticides, education programs, bed nets, treatment drugs, and prevention drugs. Scientists are doing many things to try to stem the tide of infections, but even as progress is made in one region, infections will flare up in others. It’s like the worst game of whack-a-mole imaginable. It takes an unprecedented coordinated effort across many geographic and political lines to even make a dent, and an immense amount of funding. However, much of the current funding has plateaued, and some of the drugs that have been used for years are becoming less effective. The malaria parasite, in particular, has started to develop resistance to currently available drugs, and insecticide resistance is also becoming a challenge in many mosquito species, including the widespread and usually invasive Aedes aegypti.
This is why some scientists are looking towards a totally new approach—something radical and controversial—to end the whack-a-mole game once and for all: genetically modified mosquitoes. In theory, their widespread release could lead to the total extinction of certain species of mosquitoes, eliminating the vector for many deadly diseases. It’s an extreme idea, but a future with genetically modified mosquitoes flying freely in our world may not be that far away. This summer, genetically modified Aedes aegypti mosquitoes could be released in the U.S. for the first time, in Florida and Texas.
So, is this a sudden Jurassic Park experiment or the logical next step in controlling mosquito-borne illness? In May of this year, the EPA in Florida unanimously approved an experimental use permit for millions of genetically modified mosquitoes to be released in the Florida Keys for a landmark project. The mosquitoes are genetically modified male Aedes aegypti mosquitoes known as OX5034, branded as “Friendly” mosquitoes, developed by the company Oxitec. Aedes aegypti are an invasive species in most places they exist. Originally from Africa, they have spread worldwide to almost every tropical and subtropical area. They are often described as the cockroaches of mosquitoes; they thrive specifically around people and are hard to get rid of. They lay their eggs in any container they can find, making it difficult to control their spread. They can bite multiple people during their lifespan, creating a huge potential to spread viruses. Unfortunately for humans, they carry many harmful viruses, including Zika and dengue, often called “breakbone fever” for how painful it is.
This is why the Aedes aegypti mosquito has been targeted as a candidate for genetic modification. At the heart of the so-called “friendly mosquito” is something called a self-limiting gene. It starts with Aedes aegypti mosquito eggs, which are injected with short pieces of DNA that contain the self-limiting gene sequence along with a fluorescence gene that acts as a marker. This lethal gene is a tetracycline transcriptional activator variant (or tTAV gene). Once introduced into the mosquito’s genome, it encodes a protein that blocks transcriptional machinery for several other genes essential to mosquito development. Without these essential genes being expressed, the mosquito larvae die before becoming adults.
However, simply injecting the tTAV gene into these eggs would only be useful in killing the handful of mosquitoes you give it to. For the gene technology to be effective, the mosquitoes need to pass the lethal gene down to their offspring. For this reason, the lethal gene has a corresponding antidote. The larvae can be given tetracycline, a common antibiotic, which allows them to survive until adulthood when the gene is no longer lethal. In the lab, mosquito eggs are injected with the self-limiting gene, and the larvae are reared in water containing tetracycline. This way, they can develop normally into adult mosquitoes. When adult genetically modified mosquitoes are released and breed with wild non-GM mosquitoes, their offspring inherit the lethal tTAV gene, and without tetracycline in their environment, they do not survive into adulthood. Over time, with enough GM mosquitoes released, this technology has the potential to significantly suppress the numbers of mosquitoes in the wild.
To enhance the technology’s effectiveness, scientists have recently found a way to ensure that the lethal gene only kills female offspring. This allows the gene to kill more mosquitoes across multiple generations until it eventually disappears from the gene pool after about ten generations. If effective, this friendly mosquito technology could almost completely protect communities from dengue, yellow fever, Zika, and other mosquito-borne illnesses carried by the Aedes aegypti mosquito, without needing insecticides. The hope is that soon this same technology could be applied to other damaging mosquito species, including the Anopheles mosquito that carries malaria.
The newest iteration of the technology is slated for possible testing in Florida at the end of the summer, followed by Texas. However, these trials will not be the first time GM mosquitoes have been tested in the wild. Previous generations of the technology have already been tested in field trials in Panama, the Cayman Islands, Malaysia, and Brazil.
The field trials in Brazil began in 2011 with the first generation of the friendly mosquito technology, OX513A. The studies were conducted in the semi-arid northeast of Brazil, in suburbs with a high incidence of dengue, where Aedes aegypti thrived due to stored water and a high human population. Male mosquitoes with the lethal gene insertion were dispersed in the study area, and their offspring, having inherited the tTAV gene, could not survive. Oxitec reports that in this study, the local Aedes aegypti population was reduced by 80 to 95 percent after a year of consistent releases. Some critics of the study claim that the suppression was more like 60 to 70 percent, but even still, that is far better than traditional methods like insecticide spraying, which rarely achieve more than 50 percent suppression.
Since then, Oxitec has also tested their second generation of friendly mosquitoes, OX5034, in Brazil and achieved similar results, with reports of up to 98 percent suppression in just a 13-week window. This is the same technology that has been granted an experimental use permit for field trials in Florida and Texas. These places currently do not have devastating mosquito-borne disease outbreaks like many areas in the tropics, but dengue and Zika have both worryingly appeared in these regions in recent years. Health officials are trying to keep these diseases at bay, and their occurrence is an ever-present possibility.
While the results from the field trials so far have been promising, the question on everyone’s mind is: Is it safe? Experiments with GM mosquitoes are often compared to Jurassic Park, implying that these experiments could lead to drastic and uncontrollable outcomes. While it is impossible to foresee every outcome, the technology can be assessed based on what we know about it and genetics in general. The main risk that opponents of this technology want to avoid is the potential for harm to humans, which is an important and valid concern. Critics claim that there is a risk that the genes from the GM mosquito could be transferred to humans or other animals that have been bitten. However, a GM mosquito biting a human is unlikely to begin with because only the females bite, and the females are engineered to die.
In the unlikely event that some females do survive and bite people, the transfer of genetic material from mosquito to human just doesn’t happen. Numerous studies have shown that livestock or chickens that eat GM corn, for example, do not have any trace of the genetic material in their bodies after eating it. Horizontal gene transfer is a commonly cited worry and should continue to be studied rigorously, but with all the information we have so far, this scenario seems extremely unlikely.
Other risks that critics cite include potential impacts on the environment. A major concern is whether killing off mosquitoes will harm the food chain, leaving birds, frogs, and other animals with less to eat. This would certainly be a significant concern if we were to eradicate all species of mosquitoes globally. For reference, there are 3,500 different species of mosquitoes around the world, and 80 species occur in Florida and 85 in Texas. However, the studies proposed in Florida and Texas only focus on one species, the Aedes aegypti, which is also an invasive species in both places. Because it’s non-native to the area, it has not co-evolved with other organisms in the ecosystem and is not a keystone species that other animals need for food.
If we do want to eliminate all disease-carrying mosquitoes in the future, this question will need to be studied more carefully. Of the 112 genera of mosquitoes, just three bear the primary responsibility for the spread of human diseases. There are many factors involved in assessing the risks of a new technology like this, and I can’t begin to address them all here. If you want to read more about the risk assessments done, there is a 140-page document addressing many of the concerns put forth by the public regarding Oxitec’s GM mosquitoes, which I will link below.
Oxitec has undergone rigorous testing to ensure their technology is safe, but you can never be 100 percent sure that it’s foolproof. This is where the debate comes in. A previously planned release in the Florida Keys of an earlier version of Oxitec’s GM mosquito was withdrawn after a referendum indicated significant opposition from local residents. More recently, the public forum on Oxitec’s recent permit application garnered 31,000 comments opposing the release and 56 in support. Before the study can proceed, it needs final approval from the mosquito control district, and it is not guaranteed that this will happen.
Many people oppose testing this technology without fully understanding it, but some concerns regarding the bias of Oxitec’s risk assessment are valid. Yes, the research Oxitec is conducting needs to be transparent, with independent research done to remove any bias. Ultimately, a new technology to fight mosquito-borne illness is desperately needed, and this looks like it could one day provide the solution that could save millions of lives.
Our modern world is increasingly shaped by our understanding of genetics, with major breakthroughs in GMOs and gene editing in recent years. In the next video, I will discuss CRISPR and how it is already reshaping our understanding of disease. Genetic advances like this are extremely complex and inherently come with a lot of uncertainty, leading to much controversy. However, genetic engineering is going to be a part of our future.
If you want to learn more about genetics, you should sign up for Curiosity Stream. Curiosity Stream is a streaming platform that has thousands of high-quality documentaries, including one called “Dynamic Genomes,” which explores how the so-called “junk” part of our DNA may actually work to determine our personal characteristics and tendencies. It’s a great overview of how mysterious and complicated our genetics really are, without skimping on the science.
If you’re a fan of educational content and have accepted that this lockdown will never be over, then this is the perfect time to sign up. A subscription to Curiosity Stream now also comes with a subscription to Nebula, a platform where top educational content creators can create videos freely without worrying about the YouTube algorithm or demonetization. It’s a place where we can upload our content ad-free and experiment with original content and new series.
If you sign up for Curiosity Stream at curiositystream.com/realscience, you’ll get a subscription to both Curiosity Stream and Nebula for just $14.79 for the whole year. By signing up, you’re not just supporting this channel but all of your favorite educational content creators.
Thanks for watching! If you would like to see more from me, the links to my Instagram, Twitter, and Patreon are below.
—
This version removes any promotional links and maintains a neutral tone while summarizing the content.
Mosquitoes – Small flying insects known for feeding on blood and acting as vectors for various diseases. – Mosquitoes are responsible for transmitting malaria, which affects millions of people worldwide.
Diseases – Disorders or malfunctions in living organisms that can be caused by pathogens, genetic factors, or environmental influences. – The spread of infectious diseases can be exacerbated by changes in climate and habitat destruction.
Genetics – The study of heredity and the variation of inherited characteristics in living organisms. – Advances in genetics have allowed scientists to understand the hereditary patterns of certain diseases.
Environmental – Relating to the natural world and the impact of human activity on its condition. – Environmental factors such as pollution and deforestation can significantly affect biodiversity.
Populations – Groups of individuals belonging to the same species that live in a shared geographic area and interbreed. – The study of populations helps ecologists understand the dynamics of species survival and reproduction.
Resistance – The ability of an organism to withstand or repel a particular threat, such as a disease or environmental stressor. – The development of antibiotic resistance in bacteria poses a significant challenge to public health.
Vector – An organism, often an insect, that transmits a pathogen from one host to another. – The Anopheles mosquito is a well-known vector for the malaria parasite.
Engineering – The application of scientific principles to design and build systems, often used in the context of genetic engineering to modify organisms. – Genetic engineering has enabled the development of crops that are more resistant to pests and environmental stress.
Trials – Systematic tests or experiments conducted to evaluate the efficacy and safety of a particular intervention or treatment. – Clinical trials are essential for determining the effectiveness of new vaccines before they are approved for public use.
Health – The state of complete physical, mental, and social well-being, not merely the absence of disease or infirmity. – Public health initiatives aim to improve the health of populations by addressing factors such as nutrition, sanitation, and access to medical care.
